Society of Regenerative Sciences (India)

(Formerly known as Stem Cell Society (India))

Event Registration Membership Form

International Publications On Alzheimers Dementia

Alzheimers Dementia Publications International

  1. Van den Bos J, Ouaamari YE, Wouters K, Cools N, Wens I. Are Cell-Based Therapies Safe and Effective in the Treatment of Neurodegenerative Diseases? A Systematic Review with Meta-Analysis. Biomolecules. 2022 Feb 21;12(2):340. doi: 10.3390/biom12020340. PmiD: 35204840; PMCID: PMC8869169.
  2. Duma C, Kopyov O, Kopyov A, et al. Human intracerebroventricular (ICV) injection of autologous, non-engineered, adipose-derived stromal vascular fraction (ADSVF) for neurodegenerative disorders: results of a 3-year phase 1 study of 113 injections in 31 patients. Mol Biol Rep. 2019;46:5257–5272.
  3. Kim HJ, Seo SW, Chang JW, Lee JI, Kim CH, Chin J, Choi SJ, Kwon H, Yun HJ, Lee JM, Kim ST, Choe YS, Lee KH, Na DL. Stereotactic brain injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer's disease dementia: A phase 1 clinical trial. Alzheimers Dement (N Y). 2015 Jul 26;1(2):95-102. doi: 10.1016/j.trci.2015.06.007. PmiD: 29854930; PMCID: PMC5975048.
  4. He Y, Jin X, Wang J, Meng M, Hou Z, Tian W, Fu L. Umbilical cord-derived mesenchymal stem cell transplantation for treating elderly vascular dementia. Cell Tissue Bank. 2017;18(1):53–59.
  5. Vaquero J, Zurita M, Mucientes J, Pascual ML, Fernández-Mateos C, Garcia E, Fernández-Guinea S. Intrathecal cell therapy with autologous stromal cells increases cerebral glucose metabolism and can offer a new approach to the treatment of Alzheimer’s type dementia. Cytotherapy. 2019.
  6. Kim HJ, Cho KR, Jang H, Lee NK, Jung YH, Kim JP, Lee JI, Chang JW, Park S, Kim ST, Moon SW, Seo SW, Choi SJ, Na DL. Intracerebroventricular injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer's disease dementia: a phase I clinical trial. Alzheimers Res Ther. 2021 Sep 14;13(1):154. doi: 10.1186/s13195-021-00897-2. PmiD: 34521461; PMCID: PMC8439008.
  7. Master YL, Tian BW, Jin MX, Hou PZ, Liu MY, Zhang BY, Luo BF, Su MJ, Wang BJ, Meng PM, He PY. A clinical research of 16 cases of human umbilical cord mesenchymal stem cells for curing senile vascular dementia. Transpl Immunol. 2022 Jul 11:101669.
  8. Arber C, Toombs J, Lovejoy C, et al. Familial Alzheimer’s disease patient-derived neurons reveal distinct mutation-specific effects on amyloid beta. Mol Psychiatry. 2020;25:2919–2931.
  9. Tsolaki M, Zygouris S, Tsoutsikas V, et al. Treatment with adipose stem cells in a patient with moderate Alzheimer’s disease: case report. J Neurorestoratol. 2015;3(1):115-120.
  10. Rash BG, Ramdas KN, Agafonova N, Naioti E, McClain-Moss L, Zainul Z, Varnado B, Peterson K, Brown M, Leal T, Kopcho S, Carballosa R, Patel P, Brody M, Herskowitz B, Fuquay A, Rodriguez S, Jacobson AF, Leon R, Hare JM. Allogeneic mesenchymal stem cell therapy with laromestrocel in mild Alzheimer’s disease: a randomized controlled phase 2a trial. Nat Med. 2025.
  11. De Jesus Gonçalves R, Vasques J, Da Silva-Junior A, Gubert F, Mendez-Otero R. Mesenchymal stem cell- and extracellular vesicle-based therapies for Alzheimer′s disease: progress, advantages, and challenges. Neural Regen Res. 2022;18(8).
  12. Zhang K, Du X, Gao Y, Liu S, Xu Y. Mesenchymal stem cells for treating Alzheimer’s disease: cell therapy and chemical reagent pretreatment. J Alzheimers Dis. 2023;93(3):863–878.
  13. Feng Q, Chen F, Liu R, Li D, Feng H, Yang J. Mesenchymal stem cell application in Alzheimer’s disease. Regen Ther. 2025;30:439–445.
  14. Alidoust L, Akhoondian M, Atefi AH, Keivanlou M, Ch MH, Jafari A. Stem cell-conditioned medium is a promising treatment for Alzheimer’s disease. Behav Brain Res. 2023;452:114543.